Efficacy, safety and pharmacokinetics (PK) of zurletrectinib, a next-generation pan-TRK inhibitor, in pediatric and adolescent patients (pts) with NTRK fusion-positive (NTRK+) solid tumors.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Yizhuo Zhang, Huanmin Wang, Yeming Wu, Suying Lu, Junting Huang, Jia Zhu, Feifei Sun, Juan Wang, Wei Yang, Zhixiang Wu, Jie Gao, Xuan Pu, Sizhe Chen, Xin Liu, Yuhan Shan, Tong Li, Bin Zhang, Renbin Zhao, Rui-Hua Xu
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410804923